169 related articles for article (PubMed ID: 16162092)
1. Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.
Blumenthal DT; Schulman SF
Expert Rev Neurother; 2005 Sep; 5(5):683-90. PubMed ID: 16162092
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma multiforme: evidence-based approach to therapy.
Nicholas MK
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of pediatric gliomas: implications for the development of future therapies.
Pytel P
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S51-60. PubMed ID: 18076319
[TBL] [Abstract][Full Text] [Related]
4. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
5. The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma.
Cloughesy T
Semin Oncol; 2011 Dec; 38 Suppl 4():S11-20. PubMed ID: 22078643
[TBL] [Abstract][Full Text] [Related]
6. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
9. Present and potential future issues in glioblastoma treatment.
Lefranc F; Sadeghi N; Camby I; Metens T; Dewitte O; Kiss R
Expert Rev Anticancer Ther; 2006 May; 6(5):719-32. PubMed ID: 16759163
[TBL] [Abstract][Full Text] [Related]
10. Clinical monograph: Clinical considerations for older patients with glioblastoma.
Abrey LE; Iwamoto FM; Finnegan T
Clin Adv Hematol Oncol; 2010 Jan; 8(1 Suppl 1):1-14; quiz 15-6. PubMed ID: 20237435
[No Abstract] [Full Text] [Related]
11. [New therapeutic options in therapy of glioblastoma multiforme].
Lakomý R; Burkon P; Burkonová D; Jancálek R
Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
Hsieh PC; Chandler JP; Bhangoo S; Panagiotopoulos K; Kalapurakal JA; Marymont MH; Cozzens JW; Levy RM; Salehi S
Neurosurgery; 2005 Oct; 57(4):684-92; discussion 684-92. PubMed ID: 16239880
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for glioblastoma.
Aghi M; Chiocca EA
Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
[TBL] [Abstract][Full Text] [Related]
15. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
Glantz M; Kesari S; Recht L; Fleischhack G; Van Horn A
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S17-24. PubMed ID: 19660679
[TBL] [Abstract][Full Text] [Related]
16. Molecular predictors in glioblastoma: toward personalized therapy.
Colman H; Aldape K
Arch Neurol; 2008 Jul; 65(7):877-83. PubMed ID: 18625854
[TBL] [Abstract][Full Text] [Related]
17. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
18. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW
Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377
[TBL] [Abstract][Full Text] [Related]
20. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]